摘要
在药品和医疗器械评价中,利用真实世界数据开展研究得到各国政府监管决策机构的重视,各国相继出台政策法规支持采用这类研究证据来评估产品的安全性和有效性。真实世界数据多源异构,开展高质量的真实世界数据研究需要多学科共同参与。在真实世界药品和医疗器械疗效比较研究中,当内对照难以获得时,设置合适的外对照有助于结果的合理解读和促进证据转化。
In the evaluation of drugs and medical devices,regulatory departments in various countries pay increasing attention to studies using real-world data,and have successively developed policies and regulations for applying real-world evidence to the safety and effectiveness evaluation of medical products.Real-world data are multi-source and heterogeneous,and conducting high-quality studies using these data involves multiple disciplines.In real-world drug and medical device comparative effectiveness research,when internal controls are not available,using an appropriate external control will be helpful for result and evidence transformation.
作者
李戈
杨智荣
赵厚宇
孙凤
詹思延
LI Ge;YANG Zhi-rong;ZHAO Hou-yu;SUN Feng;ZHAN Si-yan(Public Health Science and Engineering College of Tianjin University of Traditional Chinese Medicine;Computer Science and Control Engineering,Shenzhen Institute of Advanced Technology,Chinese Academy of Sciences;Primary Care Unit,School of Clinical Medicine,University of Cambridge;Department of Epidemiology and Biostatistics,School of Public Health,Peking University)
出处
《中国食品药品监管》
2021年第11期56-61,共6页
China Food & Drug Administration Magazine
关键词
真实世界数据
外对照
药品/医疗器械评价
疗效比较研究
real-world data
external control
drug and medical device evaluation
comparative effectiveness research